Leerink Partners Downgrades 10X Genomics (TXG) to Market Perform
Leerink Partners analyst Puneet Souda downgraded 10X Genomics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
